| 000 | 02427nam a2200325 i 4500 | ||
|---|---|---|---|
| 999 |
_c399495 _d399495 |
||
| 001 | 399495 | ||
| 003 | ES-MaUEC | ||
| 005 | 20240426163036.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 231205s2023 sz | fo |||| 0|eng d | ||
| 020 | _a9783031382376 | ||
| 024 | 7 |
_a10.1007/978-3-031-38237-6 _2doi |
|
| 040 |
_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aQH442 _b2023 EB |
|
| 100 | 1 |
_aRegnault-Roger, Catherine _eautor _4aut _4http://id.loc.gov/vocabulary/relators/aut _9690126 |
|
| 245 | 1 | 0 |
_aBiotech Challenges _cby Catherine Regnault-Roger |
| 250 | _a1st ed. 2023 | ||
| 264 | 1 |
_aCham _bSpringer Nature Switzerland _c2023 |
|
| 300 | _a1 recurso en línea | ||
| 336 |
_atexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 520 | _aThis book is a translation of an original French edition. The translation was done with the help of artificial intelligence. A subsequent human revision was done primarily in terms of content, so that the book will read stylistically differently from a conventional translation. The evolution of genome's modification by genetic engineering was characterized by a major technological breakthrough with the discovery of CRISPR in 2012. A distinction is now made between first-generation biotechnologies developed in the 20th century and current second-generation biotechnologies, NGT or New Genomic Techniques, including genome editing. How do we consider these genomic modifications compared to those that occur spontaneously in nature? What are the applications of these techniques in the fields of plants, animals, and human health? What prospects in terms of development and independence for countries and at least what regulations are in force on the different continents? The book questions what GMOs are, genome editing products and the place of genomic transformations today and tomorrow in our societies. It tries to give some geostrategic and regulatory benchmarks on biotech products in order to better understand the current issues. | ||
| 988 | _aSpringer_BiomedLife_2023 | ||
| 650 | 7 |
_2embne _9141520 _aIngeniería genética |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-38237-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_b04/2024 _dq _eb _zSI |
||